Sameh Tawfik

Array ( [id] => 9721092 [patent_doc_number] => 20140256794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-09-11 [patent_title] => 'ACTIVATION OF FUNCTIONAL NUCLEIC ACID BY SPECIFIC MODIFICATION' [patent_app_type] => utility [patent_app_number] => 14/352884 [patent_app_country] => US [patent_app_date] => 2012-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 21 [patent_no_of_words] => 19002 [patent_no_of_claims] => 17 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14352884 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10831583 [patent_doc_number] => 08859752 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-10-14 [patent_title] => 'SIRNA-based therapy of Fibrodyplasia Ossificans Progressiva (FOP)' [patent_app_type] => utility [patent_app_number] => 13/654208 [patent_app_country] => US [patent_app_date] => 2012-10-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 10 [patent_figures_cnt] => 10 [patent_no_of_words] => 14452 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 69 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13654208 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10008063 [patent_doc_number] => 09051570 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-06-09 [patent_title] => 'UNA oligomers for therapeutics' [patent_app_type] => utility [patent_app_number] => 13/652965 [patent_app_country] => US [patent_app_date] => 2012-10-16 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 9 [patent_no_of_words] => 25015 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 34 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13652965 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9015959 [patent_doc_number] => 20130230923 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-09-05 [patent_title] => 'Short Interfering Ribonucleic Acid (siRNA) for Oral Administration' [patent_app_type] => utility [patent_app_number] => 13/651808 [patent_app_country] => US [patent_app_date] => 2012-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 18 [patent_figures_cnt] => 18 [patent_no_of_words] => 11547 [patent_no_of_claims] => 21 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13651808 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10382186 [patent_doc_number] => 20150267193 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-09-24 [patent_title] => 'MicroRNAs and Methods of Using Same' [patent_app_type] => utility [patent_app_number] => 13/651672 [patent_app_country] => US [patent_app_date] => 2012-10-15 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 23869 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13651672 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8830099 [patent_doc_number] => 20130131143 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-05-23 [patent_title] => 'RTP801L SIRNA COMPOUNDS AND METHODS OF USE THEREOF' [patent_app_type] => utility [patent_app_number] => 13/651123 [patent_app_country] => US [patent_app_date] => 2012-10-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 11 [patent_figures_cnt] => 11 [patent_no_of_words] => 75788 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13651123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9323763 [patent_doc_number] => 08658785 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-02-25 [patent_title] => 'siRNA targeting tie-2' [patent_app_type] => utility [patent_app_number] => 13/647869 [patent_app_country] => US [patent_app_date] => 2012-10-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 36293 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 46 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13647869 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9401914 [patent_doc_number] => 08691967 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2014-04-08 [patent_title] => 'Multiple promoter expression cassettes for simultaneous delivery of RNAi agents' [patent_app_type] => utility [patent_app_number] => 13/627644 [patent_app_country] => US [patent_app_date] => 2012-09-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 32 [patent_no_of_words] => 19586 [patent_no_of_claims] => 16 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13627644 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9656703 [patent_doc_number] => 20140227708 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2014-08-14 [patent_title] => 'METHODS AND KITS USED IN IDENTIFYING MICRORNA TARGETS' [patent_app_type] => utility [patent_app_number] => 14/236619 [patent_app_country] => US [patent_app_date] => 2012-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 25 [patent_figures_cnt] => 25 [patent_no_of_words] => 23216 [patent_no_of_claims] => 48 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14236619 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 10414685 [patent_doc_number] => 20150299695 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2015-10-22 [patent_title] => 'MULTIMERIC OLIGONUCLEOTIDES COMPOUNDS' [patent_app_type] => utility [patent_app_number] => 14/344523 [patent_app_country] => US [patent_app_date] => 2012-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 45 [patent_figures_cnt] => 45 [patent_no_of_words] => 37265 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 14 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14344523 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9964309 [patent_doc_number] => 09011919 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-04-21 [patent_title] => 'Compositions for targeted delivery of siRNA' [patent_app_type] => utility [patent_app_number] => 13/615938 [patent_app_country] => US [patent_app_date] => 2012-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 6 [patent_no_of_words] => 24548 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13615938 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 11930913 [patent_doc_number] => 09797904 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2017-10-24 [patent_title] => 'Use of isocitrate dehydrogenase 1 as a diagnostic and prognostic biomarker and therapeutic target for lung cancers' [patent_app_type] => utility [patent_app_number] => 14/428334 [patent_app_country] => US [patent_app_date] => 2012-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 12 [patent_figures_cnt] => 18 [patent_no_of_words] => 9775 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 181 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 14428334 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9983810 [patent_doc_number] => 09029525 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2015-05-12 [patent_title] => 'Compositions and methods for inhibiting expression of GSK-3 genes' [patent_app_type] => utility [patent_app_number] => 13/615164 [patent_app_country] => US [patent_app_date] => 2012-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 7 [patent_no_of_words] => 73618 [patent_no_of_claims] => 23 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 72 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13615164 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8618134 [patent_doc_number] => 20130023446 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-24 [patent_title] => 'siRNA Targeting Beta Secretase (BACE)' [patent_app_type] => utility [patent_app_number] => 13/613910 [patent_app_country] => US [patent_app_date] => 2012-09-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 44 [patent_figures_cnt] => 44 [patent_no_of_words] => 35295 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13613910 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8710317 [patent_doc_number] => 20130067606 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'MODULATING PRODUCTION TRAITS IN AVIANS' [patent_app_type] => utility [patent_app_number] => 13/602927 [patent_app_country] => US [patent_app_date] => 2012-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10205 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13602927 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8638239 [patent_doc_number] => 20130030042 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-31 [patent_title] => 'NUCLEIC ACIDS FOR TARGETING MULTIPLE REGIONS OF THE HCV GENOME' [patent_app_type] => utility [patent_app_number] => 13/602886 [patent_app_country] => US [patent_app_date] => 2012-09-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 22020 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13602886 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8586972 [patent_doc_number] => 20130005794 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-01-03 [patent_title] => 'METHODS AND SEQUENCES TO SUPPRESS PRIMATE HUNTINGTON GENE EXPRESSION' [patent_app_type] => utility [patent_app_number] => 13/601198 [patent_app_country] => US [patent_app_date] => 2012-08-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 24 [patent_figures_cnt] => 24 [patent_no_of_words] => 13851 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13601198 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8708769 [patent_doc_number] => 20130066058 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-03-14 [patent_title] => 'Use of Antisense Oligonucleotides or siRNA to Suppress Expression of eIF-5A1' [patent_app_type] => utility [patent_app_number] => 13/572123 [patent_app_country] => US [patent_app_date] => 2012-08-10 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 101 [patent_figures_cnt] => 101 [patent_no_of_words] => 33090 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13572123 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 8685145 [patent_doc_number] => 20130053428 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2013-02-28 [patent_title] => 'NATURAL ANTISENSE AND NON-CODING RNA TRANSCRIPTS AS DRUG TARGETS' [patent_app_type] => utility [patent_app_number] => 13/563581 [patent_app_country] => US [patent_app_date] => 2012-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 23 [patent_figures_cnt] => 23 [patent_no_of_words] => 40600 [patent_no_of_claims] => 34 [patent_no_of_ind_claims] => 15 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13563581 [rel_patent_id] =>[rel_patent_doc_number] =>)

Array ( [id] => 9183418 [patent_doc_number] => 08623350 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2014-01-07 [patent_title] => 'Protease inhibitor: protease sensitivity expression system and method improving the therapeutic activity and specificity of proteins and phage and phagemids delivered by bacteria' [patent_app_type] => utility [patent_app_number] => 13/562488 [patent_app_country] => US [patent_app_date] => 2012-07-31 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 7 [patent_figures_cnt] => 11 [patent_no_of_words] => 11288 [patent_no_of_claims] => 20 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 105 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 13562488 [rel_patent_id] =>[rel_patent_doc_number] =>)